Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time.
In lung transplant patients undergoing immunosuppression, more than one human cytomegalovirus (HCMV) genotype may emerge during follow-up, and this could be critical for the outcome of HCMV infection. Up to now, many cases of infection with multiple HCMV genotypes were probably overlooked due to the limitations of the current genotyping approaches. We have now analyzed mixed-genotype infections in 17 clinical samples from 9 lung transplant patients using the highly sensitive ultradeep-pyrosequencing (UDPS) technology. UDPS genotyping was performed at three variable HCMV genes, coding for glycoprotein N (gN), glycoprotein O (gO), and UL139. Simultaneous analysis of a mean of 10,430 sequence reads per amplicon allowed the relative amounts of distinct genotypes in the samples to be determined down to 0.1% to 1% abundance. Complex mixtures of up to six different HCMV genotypes per sample were observed. In all samples, no more than two major genotypes accounted for at least 88% of the HCMV DNA load, and these were often accompanied by up to four low-abundance genotypes at frequencies of 0.1% to 8.6%. No evidence for the emergence of new genotypes or sequence changes over time was observed. However, analysis of different samples withdrawn from the same patients at different time points revealed that the relative levels of replication of the individual HCMV genotypes changed within a mixed-genotype population upon reemergence of the virus. Our data show for the first time that, similar to what has been hypothesized for the murine model, HCMV reactivation in humans seems to occur stochastically.
Görzer
Irene
I
Medical University of Vienna, Department of Virology, Kinderspitalgasse 15, A-1095 Vienna, Austria.
Guelly
Christian
C
Trajanoski
Slave
S
Puchhammer-Stöckl
Elisabeth
E
D000818:Animals; D001483:Base Sequence; D003587:Cytomegalovirus / Q000145:classification / Q000235:genetics*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000821:virology*; D004279:DNA, Viral / Q000235:genetics; D005838:Genotype; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects; D051379:Mice; D008969:Molecular Sequence Data; D010802:Phylogeny; D016415:Sequence Alignment; D017422:Sequence Analysis, DNA / Q000379:methods; D013997:Time Factors; D019562:Viral Load
D004279:DNA, Viral
Virology. 2009 Aug 1;390(2):330-7
19524994
J Gen Virol. 2003 Mar;84(Pt 3):647-655
12604817
Clin Infect Dis. 2008 Mar 15;46(6):831-9
18269330
Microbes Infect. 2008 Oct;10(12-13):1363-9
18761415
Clin Infect Dis. 2009 Oct 15;49(8):1160-6
19751151
J Virol. 1999 Oct;73(10):8612-22
10482614
Mol Biol Evol. 2007 Aug;24(8):1596-9
17488738
J Med Virol. 2008 Aug;80(8):1405-14
18551598
J Med Virol. 2005 Jan;75(1):42-6
15543586
J Gen Virol. 2001 Nov;82(Pt 11):2777-2784
11602789
Lancet. 1998 Oct 17;352(9136):1280-1
9788461
J Clin Microbiol. 2008 Dec;46(12):4004-10
18971365
Virology. 2008 Aug 15;378(1):86-96
18556037
J Virol. 2002 Nov;76(21):10841-8
12368327
J Exp Med. 1994 Jan 1;179(1):185-93
8270864
J Virol. 2005 Aug;79(15):9492-502
16014912
Clin Microbiol Rev. 1997 Jan;10(1):86-124
8993860
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14223-8
14623981
J Gen Virol. 2005 Nov;86(Pt 11):2949-2954
16227215
Genome Res. 2007 Aug;17(8):1195-201
17600086
Am J Transplant. 2009 Nov;9(11):2453-8
19843027
J Clin Microbiol. 2003 Jul;41(7):2872-7
12843015
J Virol. 2003 Feb;77(3):1840-7
12525618
Rev Med Virol. 2004 Nov-Dec;14(6):383-410
15386592
N Engl J Med. 2001 May 3;344(18):1366-71
11333993
Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):286-95
19682613
J Gen Virol. 2004 May;85(Pt 5):1301-1312
15105547
Am J Transplant. 2004 Aug;4(8):1219-26
15268722
Curr Top Microbiol Immunol. 2008;325:315-31
18637514
J Virol Methods. 1989 Dec;26(3):345-9
2559924
J Virol. 2005 Aug;79(16):10330-8
16051825
Transplantation. 2006 Jan 27;81(2):187-94
16436961
Genome Biol. 2007;8(7):R143
17659080
Curr Top Microbiol Immunol. 2008;325:297-313
18637513
J Gen Virol. 2009 Aug;90(Pt 8):1951-1961
19420160
Lancet Infect Dis. 2004 Dec;4(12):725-38
15567122
J Clin Virol. 2006 Aug;36(4):239-48
16697698
J Med Virol. 2008 Sep;80(9):1615-23
18649324
J Virol. 2004 Sep;78(18):10023-33
15331735
J Gen Virol. 2010 Mar;91(Pt 3):605-15
19906940
J Virol. 2005 Jan;79(1):326-40
15596827
Curr Opin Immunol. 2007 Oct;19(5):577-82
17716883
J Infect Dis. 2003 Aug 15;188(4):581-4
12898447
J Virol. 1994 Mar;68(3):1597-604
8107221
J Virol. 2009 Oct;83(19):10293-8
19605491
Virus Res. 2006 Apr;117(1):90-104
16490275
Transpl Immunol. 2009 May;21(1):1-9
19162183
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5
15738399
Virol J. 2006 Jan 12;3:4
16409621
J Gen Virol. 2010 Mar;91(Pt 3):599-604
19906945
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Virology. 2004 Jan 20;318(2):582-97
14972526
J Clin Microbiol. 2008 Mar;46(3):882-6
18216215